Fractions of Rep+CD68+ MPs among all MPs were increased in tumor-distant (mean 27.0%) and peritumor (23.1%) tissues of CRC patients compared to tumor tissues (4.7%, p < 0.0001 and p < 0.01). This evidence concerns the gene CD68 and colorectal carcinoma.